TER CFO receives RSUs and options; post-award holding 11,260 shares

Rhea-AI Filing Summary

Teradyne, Inc. (TER) reported insider equity awards to its Chief Financial Officer on 11/03/2025. The filing shows a grant of 11,144 restricted stock units (RSUs) at $0, and a stock option to buy 9,156 shares with a $183.07 exercise price.

The RSUs vest in four equal annual installments beginning on November 3, 2026. The option vests 25% per year over four years beginning on November 3, 2026, and expires on November 3, 2032. Following the transactions, the officer beneficially owned 11,260 shares of common stock directly.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Turner Michelle L.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	9,156	$0.00	--
Grant/Award	Common Stock	11,144	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 9,156 shares (Direct); Common Stock — 11,260 shares (Direct)

Footnotes (1)

1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2006 Equity and Cash Compensation Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest in four equal annual installments beginning on November 3, 2026. This option vests 25% per year over four years beginning on November 3, 2026, the first anniversary of the grant.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Turner Michelle L.

(Last) (First) (Middle)

C/O TERADYNE, INC.

600 RIVERPARK DRIVE

(Street)

NORTH READING MA 01864

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TERADYNE, INC [ TER ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/03/2025		A		11,144(1)	A	$0	11,260	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$183.07	11/03/2025		A		9,156		(2)	11/03/2032	Common Stock	9,156	$0	9,156	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2006 Equity and Cash Compensation Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest in four equal annual installments beginning on November 3, 2026.

2. This option vests 25% per year over four years beginning on November 3, 2026, the first anniversary of the grant.

	/s/ Ryan E. Driscoll, Attorney-in-Fact	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Teradyne (TER) report in this Form 4?

A grant of 11,144 RSUs and a stock option for 9,156 shares with a $183.07 exercise price to the CFO on 11/03/2025.

How do the Teradyne CFO’s RSUs vest?

The 11,144 RSUs vest in four equal annual installments beginning on November 3, 2026.

What is the vesting schedule for the CFO’s stock options at TER?

The 9,156-share option vests 25% per year over four years beginning on November 3, 2026 and expires on November 3, 2032.

What is the exercise price of the Teradyne CFO’s stock options?

The options have a $183.07 exercise price.

How many Teradyne shares did the CFO own after the reported transactions?

The filing lists 11,260 shares of common stock beneficially owned directly after the transactions.

Were the RSUs granted at a purchase price?

No. The filing shows the RSUs were granted at $0 price.